Last Updated

08 Aug 2022

Phase 1 & 2: PATH/GSK collaboration to support adoption of best clinical practices for radical cure of Plasmodium vivax in India

Objectives

The objectives of this project were:

  1. Understand the risks and opportunities associated with access to best clinical practices for managing vivax malaria in India; and
  2. Support adoption of best clinical practices for radical cure of Plasmodium vivax in India.

Principal Institution(s)

Principal Investigator
Thematic Categories

Date

2018 Apr - 2022 Oct

Funding Details

Project Site